Cancer drug helped delay progression of Duchenne muscular dystrophy in mice - Earth News Report
Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. Duchenne muscular dystrophy (DMD) is a severe genetic disorder that leads to progressive muscle weakness. Image Credit: University of British Columbia The researchers found that the drug — known as a colony-stimulating factor
